Thiopurine EnhAnced Maintenance Therapy
NCT02912676
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma
Interventions
DRUG:
Thioguanine (oral)
Sponsor
Kjeld Schmiegelow
Collaborators
[object Object]
[object Object]